AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 1 filers reported holding AMRYT PHARMA PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,285 | – | 156,694 | – | 3.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $129,138,967 | 46.27% |
| Stonepine Capital Management, LLC | 6,278,085 | $91,534,479 | 30.70% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $38,911,731 | 16.21% |
| SYQUANT CAPITAL SAS | 258,000 | $3,762 | 8.72% |
| Black Maple Capital Management LP | 545,693 | $7,956,204 | 7.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $6,557,165 | 5.42% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $92,343 | 3.40% |
| Anqa Management LLC | 156,694 | $2,285 | 3.20% |
| Black Maple Capital Management LP | 200,000 | $2,916,000 | 2.73% |
| TIG Advisors, LLC | 1,666,821 | $24,302,250 | 1.78% |